4.7 Article

NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation

期刊

CELL DEATH & DISEASE
卷 12, 期 9, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41419-021-04127-3

关键词

-

资金

  1. National Natural Science Foundation of China [32070151]
  2. Key R&D Program of Zhejiang Province [2020C03029]
  3. Zhejiang Provincial Key Research and Development Project [2021C03120]
  4. Natural Science Foundation of Zhejiang [LQ20C060003, LY20H160015]
  5. Health Commission of Zhejiang [2019KY458]

向作者/读者索取更多资源

NSUN2, a m5C RNA methyltransferase, is upregulated in gastric cancer (GC) and predicts poor prognosis. It promotes cell proliferation, migration, and invasion, possibly through direct interaction with SUMO-2/3 for nuclear transport. NSUN2 is involved in multiple cancer-related signaling pathways, with potential target genes such as PIK3R1 and PCYT1A in GC progression.
The 5-methylcytosine (m5C) RNA methyltransferase NSUN2 is involved in the regulation of cell proliferation and metastasis formation and is upregulated in multiple cancers. However, the biological significance of NSUN2 in gastric cancer (GC) and the modification of NSUN2 itself have not been fully investigated. Here, we analyzed the expression level of NSUN2 in tissue microarrays containing 403 GC tissues by immunohistochemistry. NSUN2 was upregulated in GC, and that it was a predictor of poor prognosis. NSUN2 promotes the proliferation, migration, and invasion of GC cells in vitro. We also demonstrated that small ubiquitin-like modifier (SUMO)-2/3 interacts directly with NSUN2 by stabilizing it and mediating its nuclear transport. This facilitates the carcinogenic activity of NSUN2. Furthermore, m5C bisulfite sequencing (Bis-seq) in NSUN2-deficient GC cells showed that m5C-methylated genes are involved in multiple cancer-related signaling pathways. PIK3R1 and PCYT1A may be the target genes that participate in GC progression. Our findings revealed a novel mechanism by which NSUN2 functions in GC progression. This may provide new treatment options for GC patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据